Stephan Witte becomes CMO of Adrenomed

Adrenomed AG
Appointee name
Stephan Witte


Stephan Witte has been appointed chief medical officer of Adrenomed AG in Germany where he will guide development of the company’s late-stage product for septic shock. Dr Witte was previously head of clinical science and operations at Atriva Therapeutics GmbH, a developer of antiviral therapeutics. He has also managed clinical development and regulatory affairs at France-based Inotrem SA, a biotech company specialising in inflammatory syndromes.

Dr Witte holds a diploma in chemistry and a PhD in biochemistry and immunology from the University of Konstanz in Germany.

Adrenomed announced the appointment on 1 February 2023.

Copyright 2023 Evernow Publishing Ltd